Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Inge Henter

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Blood|September 21, 2011
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13DMarie Meeths, Samuel C C Chiang, Stephanie M Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
American Journal of Medical Genetics. Part A|January 5, 2021
Chondrodysplasia and growth failure in children after early hematopoietic stem cell transplantation for non-oncologic disordersLorenzo D Botto, Marie Meeths, Belinda Campos-Xavier, et al.
Blood|April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisBernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
Genome Medicine|December 20, 2015
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosisBianca Tesi, Kristina Lagerstedt-Robinson, Samuel C C Chiang, et al.
Cell|September 27, 2020
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, et al.
Blood|November 22, 2023
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Katharina Wustrau, Jana Pachlopnik Schmid, et al.
Blood|July 3, 2024
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosisSamuel C C Chiang, Laura E Covill, Bianca Tesi, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Blood|September 21, 2011
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13DMarie Meeths, Samuel C C Chiang, Stephanie M Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severityEgle Kvedaraite, Laura Hertwig, Indranil Sinha, et al.
American Journal of Medical Genetics. Part A|January 5, 2021
Chondrodysplasia and growth failure in children after early hematopoietic stem cell transplantation for non-oncologic disordersLorenzo D Botto, Marie Meeths, Belinda Campos-Xavier, et al.
Blood|April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisBernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Blood|March 12, 2016
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesJean-François Emile, Oussama Abla, Sylvie Fraitag, et al.
Genome Medicine|December 20, 2015
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosisBianca Tesi, Kristina Lagerstedt-Robinson, Samuel C C Chiang, et al.
Cell|September 27, 2020
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, et al.
Blood|November 22, 2023
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Katharina Wustrau, Jana Pachlopnik Schmid, et al.
Blood|July 3, 2024
Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosisSamuel C C Chiang, Laura E Covill, Bianca Tesi, et al.
EMBO Molecular Medicine|January 18, 2020
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacySean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, et al.
Pageof 21